4//SEC Filing
Kelly Timothy Edwin 4
Accession 0001689548-25-000014
CIK 0001689548other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:50 PM ET
Size
9.1 KB
Accession
0001689548-25-000014
Insider Transaction Report
Form 4
Kelly Timothy Edwin
Chief Financial Officer
Transactions
- Award
Common Stock
2025-01-10+12,500→ 24,706 total - Tax Payment
Common Stock
2025-01-12$63.15/sh−676$42,689→ 24,030 total - Award
Stock Option (Right to Buy)
2025-01-10+25,000→ 25,000 totalExercise: $63.15Exp: 2035-01-10→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Mr. Kelly was awarded 12,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.
- [F3]The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.
Documents
Issuer
Praxis Precision Medicines, Inc.
CIK 0001689548
Entity typeother
Related Parties
1- filerCIK 0001863297
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 6:50 PM ET
- Size
- 9.1 KB